Tilray (TLRY) and Aphria (APHA) $4bn merger information including expected completion date, offer price and contact details are displayed in the acquisition details table below. An invaluable buyout factsheet for traders and investors looking to trade the merger arbitrage spread.
This deal was successfully consummated on April 30, 2021
Tilray (NASDAQ: TLRY) & Aphria (NASDAQ: APHA) Merger
Receive FREE instant access to constantly updated APHA news related to the current merger. Simply register by entering your email address to receive weekly publication updates. For more proprietary Merger Arbitrage Limited content and analysis on this buyout, click either Tilray (TLRY) or Aphria (APHA). Proprietary commentary can also be accessed by simply entering a ticker symbol into the search box such as “TLRY” or “APHA“, or clicking on a stock ticker in the tag cloud at the foot of this article.
Traders and shareholders can review similar merger details on current takeover stocks by first selecting “DEALS” from the main menu above, then “Current Cash Deals” or “Current Stock Deals“. For previous acquisitions, select either “Closed Deals” or “Failed Deals“. Additionally, check out our customized M&A PR Newswire or Business Wire press release news feeds exclusively for Merger Arbitrage Limited.
Tilray (NASDAQ: TLRY) & Aphria (NASDAQ: APHA) Merger - Acquisition News and Events
The major acquisition news updates & events of Tilray (TLRY) & Aphria (APHA) by are listed below. A comprehensive data source for
- Traders looking to familiarize themselves with the Tilray (TLRY) merger with Aphria (APHA) and trade the merger arbitrage spread
- Existing shareholders and investors wishing to stay abreast of the latest deal developments
Following the acquisition news section, there are in-depth company profiles.
Tilray Company Profile
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, Israel, Ireland, New Zealand, South Africa, Switzerland, the United States, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.
Aphria Company Profile
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P’tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Finding this information useful? Here's what you can do to help...
- Share this page using the toolbar links at the left of your screen or at the bottom for mobile users on your preferred social network
- Sina Weibo
- Twitter etc.
- Follow us on twitter @MergeArbLimited.
- Become friends with us on Facebook
- Register for news alerts and merger arbitrage deal analysis postings via email using the sign up form.
- In addition to these, an RSS feed is also available at the bottom right of the page.
- Contact us using the details given on the Contact Us page.
- Donate using the paypal widget in the sidebar. It’s gladly appreciated and we need the coffee! See the Paypal section for additional incentives
- Share this page using the toolbar links at the left of your screen or at the bottom for mobile users on your preferred social network
Thanks for reading!
